Advances in induced Pluripotent Stem cell therapy for neurological diseases

Toru Yamashita, Hiromi Kawai, Koji Abe

Research output: Contribution to journalArticle

Abstract

Induced Pluripotent Stem (iPS) cells are regarded to be potential supply source of cells for application to cell replacement therapies. Recent scientific papers indicated that human iPS cells are capable of differentiating into glutamatergic neurons, dopaminergic neurons, and motor neurons. However, tumorigenesis in iPS cells is a serious problem which should be overcome for clinical application. Recently, we evaluated the influence of ischemic condition on undifferentiated iPS cells within a transient Middle Cerebral Artery Occlusion (MCAO) using a mouse model. Undifferentiated iPS cells (5 × 10 5) were injected into the ipsilateral striatum and cortex, which were considered as the ischemic boundary zone at 24 hours after MCAO. Ischemic brains treated with iPS cells tended to form teratoma with larger volume compared with those in intact brains. c~Myc, Oct3/4 and Sox2 were strongly expressed in iPS-derived tumors of the ischemic brain. Above results indicated that the transcriptional factors integrated into the genome by retrovirus vectors might promote teratoma formation in the ischemic brain. Potential interaction between integrated transcriptional factors and iPS cell characteristics needs to be kept in mind, for the development of transplantation therapy.

Original languageEnglish
Pages (from-to)585-588
Number of pages4
JournalJapanese Journal of Neurosurgery
Volume20
Issue number8
Publication statusPublished - Nov 2011

Fingerprint

Induced Pluripotent Stem Cells
Cell- and Tissue-Based Therapy
Middle Cerebral Artery Infarction
Teratoma
Brain
Dopaminergic Neurons
Motor Neurons
Retroviridae
Brain Neoplasms
Carcinogenesis
Transplantation
Genome
Neurons

Keywords

  • Cell transplantation
  • Induced pluripotent stem cells
  • Middle cerebral artery occlusion
  • Tumorigenesis

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Advances in induced Pluripotent Stem cell therapy for neurological diseases. / Yamashita, Toru; Kawai, Hiromi; Abe, Koji.

In: Japanese Journal of Neurosurgery, Vol. 20, No. 8, 11.2011, p. 585-588.

Research output: Contribution to journalArticle

@article{b91591477aef48f1a864a3d8e9be2d87,
title = "Advances in induced Pluripotent Stem cell therapy for neurological diseases",
abstract = "Induced Pluripotent Stem (iPS) cells are regarded to be potential supply source of cells for application to cell replacement therapies. Recent scientific papers indicated that human iPS cells are capable of differentiating into glutamatergic neurons, dopaminergic neurons, and motor neurons. However, tumorigenesis in iPS cells is a serious problem which should be overcome for clinical application. Recently, we evaluated the influence of ischemic condition on undifferentiated iPS cells within a transient Middle Cerebral Artery Occlusion (MCAO) using a mouse model. Undifferentiated iPS cells (5 × 10 5) were injected into the ipsilateral striatum and cortex, which were considered as the ischemic boundary zone at 24 hours after MCAO. Ischemic brains treated with iPS cells tended to form teratoma with larger volume compared with those in intact brains. c~Myc, Oct3/4 and Sox2 were strongly expressed in iPS-derived tumors of the ischemic brain. Above results indicated that the transcriptional factors integrated into the genome by retrovirus vectors might promote teratoma formation in the ischemic brain. Potential interaction between integrated transcriptional factors and iPS cell characteristics needs to be kept in mind, for the development of transplantation therapy.",
keywords = "Cell transplantation, Induced pluripotent stem cells, Middle cerebral artery occlusion, Tumorigenesis",
author = "Toru Yamashita and Hiromi Kawai and Koji Abe",
year = "2011",
month = "11",
language = "English",
volume = "20",
pages = "585--588",
journal = "Japanese Journal of Neurosurgery",
issn = "0917-950X",
publisher = "日本脳神経外科コングレス",
number = "8",

}

TY - JOUR

T1 - Advances in induced Pluripotent Stem cell therapy for neurological diseases

AU - Yamashita, Toru

AU - Kawai, Hiromi

AU - Abe, Koji

PY - 2011/11

Y1 - 2011/11

N2 - Induced Pluripotent Stem (iPS) cells are regarded to be potential supply source of cells for application to cell replacement therapies. Recent scientific papers indicated that human iPS cells are capable of differentiating into glutamatergic neurons, dopaminergic neurons, and motor neurons. However, tumorigenesis in iPS cells is a serious problem which should be overcome for clinical application. Recently, we evaluated the influence of ischemic condition on undifferentiated iPS cells within a transient Middle Cerebral Artery Occlusion (MCAO) using a mouse model. Undifferentiated iPS cells (5 × 10 5) were injected into the ipsilateral striatum and cortex, which were considered as the ischemic boundary zone at 24 hours after MCAO. Ischemic brains treated with iPS cells tended to form teratoma with larger volume compared with those in intact brains. c~Myc, Oct3/4 and Sox2 were strongly expressed in iPS-derived tumors of the ischemic brain. Above results indicated that the transcriptional factors integrated into the genome by retrovirus vectors might promote teratoma formation in the ischemic brain. Potential interaction between integrated transcriptional factors and iPS cell characteristics needs to be kept in mind, for the development of transplantation therapy.

AB - Induced Pluripotent Stem (iPS) cells are regarded to be potential supply source of cells for application to cell replacement therapies. Recent scientific papers indicated that human iPS cells are capable of differentiating into glutamatergic neurons, dopaminergic neurons, and motor neurons. However, tumorigenesis in iPS cells is a serious problem which should be overcome for clinical application. Recently, we evaluated the influence of ischemic condition on undifferentiated iPS cells within a transient Middle Cerebral Artery Occlusion (MCAO) using a mouse model. Undifferentiated iPS cells (5 × 10 5) were injected into the ipsilateral striatum and cortex, which were considered as the ischemic boundary zone at 24 hours after MCAO. Ischemic brains treated with iPS cells tended to form teratoma with larger volume compared with those in intact brains. c~Myc, Oct3/4 and Sox2 were strongly expressed in iPS-derived tumors of the ischemic brain. Above results indicated that the transcriptional factors integrated into the genome by retrovirus vectors might promote teratoma formation in the ischemic brain. Potential interaction between integrated transcriptional factors and iPS cell characteristics needs to be kept in mind, for the development of transplantation therapy.

KW - Cell transplantation

KW - Induced pluripotent stem cells

KW - Middle cerebral artery occlusion

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84055218251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84055218251&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 585

EP - 588

JO - Japanese Journal of Neurosurgery

JF - Japanese Journal of Neurosurgery

SN - 0917-950X

IS - 8

ER -